Present and future of cell-penetrating peptide mediated delivery systems: “Is the Trojan horse too wild to go only to Troy?”
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 109 (1-3) , 77-85
- https://doi.org/10.1016/j.jconrel.2005.09.032
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich PeptidesBioconjugate Chemistry, 2004
- HIV Tat Peptide Enhances Cellular Delivery of Antisense Morpholino OligomersAntisense and Nucleic Acid Drug Development, 2003
- Positively Charged DNA-Binding Proteins Cause Apparent Cell Membrane TranslocationBiochemical and Biophysical Research Communications, 2002
- Phosphoinositide 3-kinase modulation of β3-integrin represents an endogenous “braking” mechanism during neutrophil transmatrix migrationBlood, 2001
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Intercellular trafficking of VP22-GFP fusion proteinsGene Therapy, 1999
- Trojan peptides: the penetratin system for intracellular deliveryTrends in Cell Biology, 1998
- Tumor Cell Retention of Antibody Fab Fragments Is Enhanced by an Attached HIV TAT Protein-Derived PeptideBiochemical and Biophysical Research Communications, 1993
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988
- Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator proteinCell, 1988